Literature DB >> 12192147

Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists.

Axel Reinhard Stoit1, Jos Hubertus Maria Lange, Arnold Peter den Hartog, Eric Ronken, Koos Tipker, Herman Heinrich van Stuivenberg, Jessica Adriana Rigtje Dijksman, Henri Cornelis Wals, Chris Gerrit Kruse.   

Abstract

The design, synthesis and biological activities of potent pyrazole-based tricyclic CB1 receptor antagonists (2) are described. The key synthetic step involves the ring closure of the lithiated alpha, gamma-keto ester adduct (4). The optimal nitroderivative (28) in this series exhibits a high CB1 receptor affinity (pKi=7.2) as well as very potent antagonistic activity (pA2=8.8) in vitro. The regioselectivity of the pyrazole ring closure is shown to depend strongly on the aromatic substitution pattern of the applied arylhydrazine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192147     DOI: 10.1248/cpb.50.1109

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs.

Authors:  Brian F Thomas; Yanan Zhang; Marcus Brackeen; Kevin M Page; S Wayne Mascarella; Herbert H Seltzman
Journal:  AAPS J       Date:  2006-10-27       Impact factor: 4.009

Review 2.  Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.

Authors:  Patricia H Reggio
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 3.  Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction.

Authors:  Battistina Asproni; Gabriele Murineddu; Paola Corona; Gérard A Pinna
Journal:  Molecules       Date:  2021-04-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.